Catalyst Bioscience
company
About
Catalyst is a biopharmaceutical company focusing on protease therapeutics to address the disorders of coagulation systems.
- 51 - 100
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $46M
- Industries
- Biotechnology,Health Care,Life Science,Medical,Medical Device,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 1997
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Catalyst Biosciences is a drug discovery and development company. It is creating novel catalytic biopharmaceutical products based on engineered human proteases. It is developing proteases for the treatment of a broad range of diseases with a strong focus on hemostasis and inflammation. It is focused on protease therapeutics to address unmet medical needs in disorders of the coagulation systems.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$106M
Catalyst Bioscience has raised a total of
$106M
in funding over 2 rounds. Their latest funding was raised on
Mar 20, 2003 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 20, 2003 | Series Unknown | $60M | 2 | — | — | Detail |
| Dec 5, 2002 | Series Unknown | $46M | 4 |
Nomura International
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
6
Catalyst Bioscience is funded by 6 investors.
Nomura International
and Cogene Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Nomura International
|
Yes | Series Unknown |
|
|
— | Series Unknown |
|
|
— | Series Unknown |
|
|
— | Series Unknown |
|
|
— | Series Unknown |
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
